Patents by Inventor Sreeja Sreekumar

Sreeja Sreekumar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies targeting an amphiregulin-derived cell surface neo-epitope
    Patent number: 12043671
    Abstract: Antibodies and antibody-drug conjugates that selectively bind to a membrane-associated extracellular portion of a cleaved amphiregulin precursor protein; methods of using the antibodies and antibody-drug conjugates to detect and inhibit the growth of neoplastic cells; pharmaceutical compositions containing the antibodies and/or antibody-drug conjugates as the active ingredient(s); kits containing the antibodies and/or antibody-drug conjugates.
    Type: Grant
    Filed: June 9, 2022
    Date of Patent: July 23, 2024
    Assignee: Gundersen Lutheran Medical Foundation, Inc.
    Inventors: Paraic Anthony Kenny, Kristopher Andrew Lofgren, Sreeja Sreekumar
  • ANTIBODIES TARGETING AN AMPHIREGULIN-DERIVED CELL SURFACE NEO-EPITOPE
    Publication number: 20220411532
    Abstract: Antibodies and antibody-drug conjugates that selectively bind to a membrane-associated extracellular portion of a cleaved amphiregulin precursor protein; methods of using the antibodies and antibody-drug conjugates to detect and inhibit the growth of neoplastic cells; pharmaceutical compositions containing the antibodies and/or antibody-drug conjugates as the active ingredient(s); kits containing the antibodies and/or antibody-drug conjugates.
    Type: Application
    Filed: June 9, 2022
    Publication date: December 29, 2022
    Inventors: Paraic Anthony Kenny, Kristopher Andrew Lofgren, Sreeja Sreekumar